Keyword: Sanofi

The partners plan to move small molecule SHP2 inhibitor RMC-4630 into the clinic later this year.

Packaging manufacturer Gerresheimer plans to acquire Sensile Medical to help it develop a line of electronic and connected drug delivery devices.

Gilead's clinical director joins Nimbus to lead discovery; Immunocore’s CMO jumps to Tmunity; Kite taps Eisai vet to lead CAR-T sales.

Four months after Voyager's chief and founder said he would step down, the neurological disease biotech has found a new leader.

Sanofi, Verily and Sensile Medical are teaming up to develop an “all-in-one” insulin patch pump, primarily aimed at patients with Type 2 diabetes.

Sanofi recruits French auto exec to replace CFO, Molecular Partners brings on Regeneron cancer leader and GSK's head of dermatology joins Aclaris.

The agreement sees Sanofi transfer 100 employees, more than 10 drug candidates and €60 million upfront to the German service provider.

The IPO would give Avrobio the means to trial gene therapies designed to supplant enzyme replacement therapies from Sanofi, Shire and Pfizer.

PPD and its real-world data unit Evidera will be the first CRO to join MIT’s biotech think tank, starting with an evidence generation pilot project.

Sanofi is trumpeting new data for a hemophilia A drug developed by Bioverativ that it says could transform treatment of the bleeding disorder.